Full Length Research Paper
References
|
Adefuye P, Broutet N, de Sanjose S, Denny L (2013). Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa. Vaccine 31(5):F53-9. |
|
|
Ajenifuja K, Gage J, Adepiti A (2013). A population-based study of visual inspection with acetic acid (VIA) for cervical screening in rural Nigeria. International Journal of Gynecologic Cancer 23:507-12. |
|
|
Arbyn M, Castellsagué X., de Sanjosé, S, Bruni L, Saraiya M, Bray F, Ferlay J (2011). Worldwide burden of cervical cancer in 2008. Annals of Oncology 22(12):2675-2686. |
|
|
Banura C, Franceschi S, van Doorn LJ, Arslan A, Kleter B, Wabwire?Mangen F, Mbidde EK, Quint W, Weiderpass E (2008). Prevalence, incidence and clearance of human papillomavirus infection among young primiparous pregnant women in Kampala, Uganda. International Journal of Cancer 123(9):2180-7. |
|
|
Blumenthal P, Gaffikin L, Deganus S, Lewis R, Emerson M, Adadevoh S (2007). Cervical cancer prevention: safety, acceptability, and feasibility of a single-visit approach in Accra, Ghana. American Journal of Obstetrics and Gynecology 196(4):407-e1 |
|
|
Blumenthal PD, Gaffi kin L, Chirenje ZM, McGrath J, Womack S, Shah K (2001). Adjunctive testing for cervical cancer in low resource set-tings with visual inspection, HPV and the Pap smear. International Journal of Gynecology and Obstetrics 72(1):47-53. |
|
|
Bradford L, Goodman A (2013). Cervical cancer screening and prevention in low-resource settings. Clinical Obstetrics and Gynecology 56:76-87. |
|
|
Bruni L, Barrionuevo-Rosas L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, Bosch FX, de Sanjosé S (2017). ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Uganda. Summary Report 27 July. |
|
|
Cronje H, Parham G, Cooreman B, de Beer A, Divall P, Bam R (2003). A comparison of four screening methods for cervical neoplasia in a developing country. American Journal of Obstetrics and Gynecology 188(2):395-400. |
|
|
Desai F, Singh LS, Majachunglu G, Kamei H (2019). Diagnostic Accuracy of Conventional Cell Blocks Along with p16INK4 and Ki67 Biomarkers as Triage Tests in Resource-poor Organized Cervical Cancer Screening Programs. Asian Pacific Journal of Cancer Prevention 20(3):917. |
|
|
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer 136(5):E359-86. |
|
|
Fokom-Domgue J, Vassilakos P, Petignat P (2014). Is screen-and-treatapproach suited for screening and management of precancerous cervical lesions in Sub-Saharan Africa? Preventive Medicine 65:138-40. |
|
|
Goldie S, Denny L, Pollack A, Wright T (2001). Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness. JAMA 285(24):3107-3115 |
|
|
Goldie S, Gaffikin L, Goldhaber-Fiebert J, (2005). Cost-effectiveness of cervical-cancer screening in five developing countries. New England Journal of Medicine 353(20):2158-2168. |
|
|
Katz I, Wright A (2006). Preventing cervical cancer in the developing world. New England Journal of Medicine 354(11):1110-1110. |
|
|
Mandelblatt J, Lawrence W, Gaffikin L (2002). Costs and benefits of different strategies to screen for cervical cancer in less-developed countries. Journal of the National Cancer Institute 94(19):1469-1483. |
|
|
Nakisige C, Schwartz M, Ndira AO (2017). Cervical cancer screening and treatment in Uganda. Gynecologic Oncology Reports.20:37-40. |
|
|
Nayar R, Wilbur DC Eds. (2015). The Bethesda system for reporting cervical cytology: definitions, criteria, and explanatory notes. Springer. |
|
|
Parkin, DM, Ferlay J, Hamdi-Cherif M, Sitas F, Thomas JO, Wabinga H, Whelan SL (2003). Cancer in Africa. Epidemiology and prevention, 4, 268-276. |
|
|
Reid R (1990). Colposcopy of cervical preinvasive neoplasia. In:Singer A, editor. Premalignant Lesions of the Lower Genital Tract 2:87-116. |
|
|
Sankaranarayanan R, Nessa A, Esmy P, Dangou J (2012). Visual inspection methods for cervical cancer prevention. Best practice and research Clinical Obstetrics and Gynaecology 26(2):221-232. |
|
|
Sankaranarayanan R, Wesley R (2003). A practical manual on visual screening for cervical neoplasia. International Agency for Research on Cancer. World Health Organization, pp.1-4. |
|
|
Sanghvi H (1998). Treatment experiences in low resource settings.In: Abwao S, Greene P, Sanghvi H, Tsu V, Winkler JL, editors. Prevention and control of cervical cancer in the east and southern Africa region. |
|
|
Sauvaget C, Fayette J, Muwonge R, Wesley R, Sankaranarayanan R (2011).Accuracy of visual inspection with acetic acid for cervical cancer screening. International Journal of Gynecology and Obstetrics 113(1):14-24. |
|
|
Sherman ME, Mendoza M, Lee KR, Ashfaq R, Birdsong GG,Corkill ME, (1998). Performance of liquid-based, thin-layercervical cytology: correlation with reference diagnoses andhuman papillomavirus testing. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc, 11(9):837-843. |
|
|
Singhal U, Lamba S, Kumar, U, Nanda A (2018). Pattern of Epithelial Cell Abnormalities on Cervical Papanicolaou Smears In Hospital Of North India: A Retrospective Study. Annals of Pathology and Laboratory Medicine 5(3):A250-255. |
|
|
Uganda Bureau of Statistics (UBOS, 2018). Health planning in Uganda: Carey, R.B., Bhattacharyya, S., Kehl, S. C., Matukas, L. M., Pentella, M. A., Salfinger, M., & Schuetz, Implementing a quality management system in the medical microbiology laboratory. Clinical Microbiology Reviews 31(3):e00062-17. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
